Specimen Mislabeling, LIS Downtime, and Inspection Readiness
A 350-bed community hospital has a pathology laboratory with two pathologists, one histotechnologist, and a send-out contract for immunohistochemistry. Frozen sections are performed Monday–Friday, 8 a.m.–5 p.m.; after-hours cases are transferred to a sister hospital 25 miles away. Last month, a breast lumpectomy specimen was mislabeled at collection: the requisition carried patient A's name, but the specimen container label carried patient B's name. The error was discovered in the gross room before processing. The laboratory information system (LIS) is scheduled for a 4-hour downtime next week for an upgrade. The hospital is preparing for a CAP inspection in 3 months and has had two corrected reports related to specimen identification in the past 6 months. The histotechnologist is scheduled for vacation during the LIS downtime.
1. What root-cause analysis and corrective actions are appropriate for the near-miss mislabeling event?
Read the worked answer
Treat this as a near-miss with high potential harm, not as a trivial catch. The root cause is likely a collection-phase failure in patient identification or labeling, but the analysis should examine the entire chain: who collected the specimen, whether two identifiers were used at collection, whether labels were applied away from the patient, whether barcode labeling was available, and whether the requisition and container were matched before transport. Corrective actions should include barcode-based bedside labeling, a two-person or two-identifier verification at collection, staff retraining, and audits of specimen labeling. Because there have been two corrected reports related to identification in 6 months, aggregate the events and look for a system pattern rather than blaming one person. Document the investigation, corrective action, and effectiveness monitoring in preparation for the CAP inspection.
2. How should the laboratory plan for the 4-hour LIS downtime with the histotechnologist on vacation?
Read the worked answer
A downtime plan must cover accessioning, grossing, histology, reporting, and reconciliation. Before the downtime, identify backup staff or reassign duties so that the histotechnologist's absence does not leave a gap. Prepare paper requisitions, downtime logs, manual accession numbers, and a list of pending cases. During downtime, maintain a chronological log of specimens received, tests ordered, and results generated, and use a defined read-back process for verbal orders. After the LIS returns, reconcile every downtime entry against the LIS and document any discrepancies. Notify operating rooms and clinics of expected delays, and define which cases are urgent enough to send to the sister hospital. Test the downtime procedure before the upgrade and debrief afterward.
3. The hospital proposes bringing immunohistochemistry in-house instead of using the send-out contract. What validation, staffing, and informatics steps should precede go-live?
Read the worked answer
Before go-live, validate each assay against the send-out laboratory or a reference method, including sensitivity, specificity, concordance, and appropriate positive and negative controls. Define which antibodies will be offered in-house and which will remain send-outs, and establish turnaround expectations. Staffing must include trained technologists, a pathologist responsible for interpretation and quality oversight, and coverage for vacation and downtime. Informatics needs include order-entry builds, result templates, interface testing, and a downtime plan for the new workflow. Because the laboratory is preparing for a CAP inspection, the validation records, competency assessments, and quality-monitoring data must be inspection-ready. Bringing testing in-house may reduce turnaround, but it should not proceed without a budget for reagents, equipment maintenance, and proficiency testing.